RUO supplier
Regulatory record only; full company profile not yet reviewed
Linked public records
Agency warning · Open public record
The FDA said Gram Peptides marketed unapproved new drugs for human use despite research-only labeling. Warning letter 721806 details the finding.
Compounds: Retatrutide, Tirzepatide
This record exists to connect a primary-source regulatory action to a company entity. It is not a current supplier assessment.
Profile ownership: unclaimed. Company representatives will be able to propose identity and catalog updates without changing editorial or regulatory records.